HeMemics is a privately held company with proprietary technologies to dehydrate biologics (proteins, cells, tissues, etc.) in dried or partially dried format for wider distribution and ease of use. The potential exists for dehydrated biologics to restore their functions after reconstitution with water or buffer. This will revolutionize the cell-based research, diagnostics and therapy markets, both human clinical and veterinary. HeMemics’ revolutionary dehydration technologies eliminate the need for biologics to be stored in aqueous or frozen formats; instead, they are stabilized in dried or partially dried format for less damage to proteins or cells, ease of storage, transport and extended shelf-life. HeMemics' technologies will fulfill unlimited market applications for dried or partially dried, stabilized biologic products for research, diagnostic and therapeutic applications.